FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4381378045> ?p ?o ?g. }

• W4381378045 abstract "Automated insulin delivery improves glycemic control in young children with type 1 diabetes (T1D). We investigated the potential impact of baseline participant characteristics on glycemic improvements when using the Tandem t:slim X2 insulin pump with Control-IQ technology (CIQ). After a 13 wk randomized, multi-center, controlled trial comparing CIQ (CLC) to standard care insulin delivery plus CGM (SC) in 102 children with T1D age 2 to &lt;6 years, 95 continued CLC for 13 wks (CLC-CLC, N=62) or transitioned to CLC (SC-CLC, N=33). We compared glycemic outcomes from the RCT to the extension phase in subgroups based on baseline characteristics. At baseline, participants were 3.9 ± 1.2 years old with 25% minority race/ethnicity; 48% household income &lt;$100,000; 57% parents with bachelor’s degree or less; 21% public insurance; 69% baseline HbA1c ≥7%; and 34% used multiple daily injections. In the SC-CLC group, time 70-180 mg/dL (TIR) improved in all subgroups regardless of race/ethnicity, family income, education, health insurance type, baseline HbA1c, and experience with devices (Table 1). In the CLC-CLC group, TIR improvement with CLC during the RCT was maintained regardless of subgroup. Our results support the findings that young children with T1D benefit from using CIQ regardless of their baseline characteristics. The benefit is maintained over a 26-week period. Disclosure L.Ekhlaspour: Consultant; Ypsomed AG, Tandem Diabetes Care, Inc., Other Relationship; NIH - National Institutes of Health, Research Support; MannKind Corporation, Tandem Diabetes Care, Inc., JDRF, Speaker's Bureau; Insulet Corporation. C.Kollman: Research Support; Insulet Corporation, Dexcom, Inc., Tandem Diabetes Care, Inc. R.Beck: Consultant; Eli Lilly and Company, Novo Nordisk, Diasome, Insulet Corporation, Research Support; Tandem Diabetes Care, Inc., Beta Bionics, Inc., Dexcom, Inc., Bigfoot Biomedical, Inc., Medtronic, Ascensia Diabetes Care, Roche Diabetes Care, Eli Lilly and Company, Novo Nordisk. M.D.Breton: Consultant; Dexcom, Inc., Tandem Diabetes Care, Inc., Roche Diabetes Care, Sanofi, Arecor, Research Support; Dexcom, Inc., Tandem Diabetes Care, Inc., Novo Nordisk. Pedap trial study group: n/a. Z.Reed: None. B.A.Buckingham: Advisory Panel; Medtronic, Novo Nordisk, Consultant; Lilly, Research Support; Medtronic, Insulet Corporation, Tandem Diabetes Care, Inc. M.D.Deboer: Research Support; Dexcom, Inc., Tandem Diabetes Care, Inc. G.P.Forlenza: Advisory Panel; Medtronic, Consultant; Dexcom, Inc., Insulet Corporation, Tandem Diabetes Care, Inc., Lilly Diabetes, Research Support; Medtronic, Abbott, Dexcom, Inc., Insulet Corporation, Tandem Diabetes Care, Inc. R.S.Kingman: None. M.Schoelwer: Research Support; Tandem Diabetes Care, Inc., Insulet Corporation. R.Wadwa: Consultant; Eli Lilly and Company, Other Relationship; Dexcom, Inc., Eli Lilly and Company, Research Support; Dexcom, Inc., Eli Lilly and Company, Beta Bionics, Inc., Tandem Diabetes Care, Inc. J.W.Lum: None. Funding National Institute of Diabetes and Digestive and Kidney Diseases (U01DK127551); Tandem Diabetes Care, Inc; Dexcom, Inc." @default.
• W4381378045 created "2023-06-21" @default.
• W4381378045 creator A5029726359 @default.
• W4381378045 creator A5047405753 @default.
• W4381378045 creator A5057738176 @default.
• W4381378045 creator A5062084555 @default.
• W4381378045 creator A5064470413 @default.
• W4381378045 creator A5070736485 @default.
• W4381378045 creator A5072070328 @default.
• W4381378045 creator A5081001216 @default.
• W4381378045 creator A5081405643 @default.
• W4381378045 creator A5085323390 @default.
• W4381378045 creator A5088396623 @default.
• W4381378045 creator A5089437051 @default.
• W4381378045 date "2023-06-20" @default.
• W4381378045 modified "2023-09-25" @default.
• W4381378045 title "924-P: Glycemic Outcomes Improved and Maintained Regardless of Demographic Characteristics of Young Children with Type 1 Diabetes Using Closed-Loop System" @default.
• W4381378045 doi "https://doi.org/10.2337/db23-924-p" @default.
• W4381378045 hasPublicationYear "2023" @default.
• W4381378045 type Work @default.
• W4381378045 citedByCount "0" @default.
• W4381378045 crossrefType "journal-article" @default.
• W4381378045 hasAuthorship W4381378045A5029726359 @default.
• W4381378045 hasAuthorship W4381378045A5047405753 @default.
• W4381378045 hasAuthorship W4381378045A5057738176 @default.
• W4381378045 hasAuthorship W4381378045A5062084555 @default.
• W4381378045 hasAuthorship W4381378045A5064470413 @default.
• W4381378045 hasAuthorship W4381378045A5070736485 @default.
• W4381378045 hasAuthorship W4381378045A5072070328 @default.
• W4381378045 hasAuthorship W4381378045A5081001216 @default.
• W4381378045 hasAuthorship W4381378045A5081405643 @default.
• W4381378045 hasAuthorship W4381378045A5085323390 @default.
• W4381378045 hasAuthorship W4381378045A5088396623 @default.
• W4381378045 hasAuthorship W4381378045A5089437051 @default.
• W4381378045 hasConcept C126322002 @default.
• W4381378045 hasConcept C134018914 @default.
• W4381378045 hasConcept C137403100 @default.
• W4381378045 hasConcept C144024400 @default.
• W4381378045 hasConcept C168563851 @default.
• W4381378045 hasConcept C1862650 @default.
• W4381378045 hasConcept C187212893 @default.
• W4381378045 hasConcept C19165224 @default.
• W4381378045 hasConcept C2777180221 @default.
• W4381378045 hasConcept C2780473172 @default.
• W4381378045 hasConcept C2781232474 @default.
• W4381378045 hasConcept C555293320 @default.
• W4381378045 hasConcept C71924100 @default.
• W4381378045 hasConceptScore W4381378045C126322002 @default.
• W4381378045 hasConceptScore W4381378045C134018914 @default.
• W4381378045 hasConceptScore W4381378045C137403100 @default.
• W4381378045 hasConceptScore W4381378045C144024400 @default.
• W4381378045 hasConceptScore W4381378045C168563851 @default.
• W4381378045 hasConceptScore W4381378045C1862650 @default.
• W4381378045 hasConceptScore W4381378045C187212893 @default.
• W4381378045 hasConceptScore W4381378045C19165224 @default.
• W4381378045 hasConceptScore W4381378045C2777180221 @default.
• W4381378045 hasConceptScore W4381378045C2780473172 @default.
• W4381378045 hasConceptScore W4381378045C2781232474 @default.
• W4381378045 hasConceptScore W4381378045C555293320 @default.
• W4381378045 hasConceptScore W4381378045C71924100 @default.
• W4381378045 hasIssue "Supplement_1" @default.
• W4381378045 hasLocation W43813780451 @default.
• W4381378045 hasOpenAccess W4381378045 @default.
• W4381378045 hasPrimaryLocation W43813780451 @default.
• W4381378045 hasRelatedWork W2161035911 @default.
• W4381378045 hasRelatedWork W2740237586 @default.
• W4381378045 hasRelatedWork W2782732109 @default.
• W4381378045 hasRelatedWork W2963647316 @default.
• W4381378045 hasRelatedWork W2972782780 @default.
• W4381378045 hasRelatedWork W2982110805 @default.
• W4381378045 hasRelatedWork W3152935002 @default.
• W4381378045 hasRelatedWork W3173876522 @default.
• W4381378045 hasRelatedWork W4293694586 @default.
• W4381378045 hasRelatedWork W4304957541 @default.
• W4381378045 hasVolume "72" @default.
• W4381378045 isParatext "false" @default.
• W4381378045 isRetracted "false" @default.
• W4381378045 workType "article" @default.